Mark Vachon, Director at bluebird bio, Inc. (BLUE), sold 6,700 shares at $219.50 ($1.5M) on 2017-12-11, disclosed to the SEC on 2017-12-13.
Open-market sale of $1.5M BLUE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $210.57 | 300 | $63K | 4.3% |
| 2 | $212.32 | 1,421 | $302K | 20.8% |
| 3 | $217.09 | 800 | $174K | 12.0% |
| 4 | $218.06 | 2,200 | $480K | 33.0% |
| 5 | $219.50 | 1,979 | $434K | 29.9% |
| Total | $216.82 avg | 6,700 |
| $1.5M |
| 100% |
| Filing → |
| BLUE | SELL | 2018-03-19 | $1.4M | — | Filing → |
| BLUE | SELL | 2017-12-13 | $1.8M | — | Filing → |
| BLUE | SELL | 2017-12-13 | $1.0M | — | Filing → |